PMU Mares and Foals – Revenue Tools at the Mercy of Big Pharma

by JANE ALLIN While it may seem that reports on the operations of Pfizer and their misguided, yet continued, use of conjugated equine estrogens to counteract the effects of menopause and osteoporosis has little to do with the plight of the horses at the center of this industry, this is furthest from the truth. Each… Continue reading PMU Mares and Foals – Revenue Tools at the Mercy of Big Pharma

Duavive —The Yellow Trail of Horse Pee Drugs Crosses the Pond to Europe

by VIVIAN FARRELL and JANE ALLIN The alleged duel-acting horse pee/bazedoxifene drug DUAVIVE—also known as DUAVEE in North America—has now made its way to the EU. Its foundation drug Premarin, which alone and in combination, has been responsible for countless cancer deaths, has now crossed international boundaries. How did this happen? Follow the trail. APRELA… Continue reading Duavive —The Yellow Trail of Horse Pee Drugs Crosses the Pond to Europe

Pushing Premarin: Big Pharma, Big Bucks — Part 3

by JANE ALLIN Advertising: Exploiting the public for power and profit Despite the controversy of PMU-derived HRT, these drugs bring in profits of over a billion dollars annually to Pfizer and it seems physicians who prescribe such drugs are indifferent to the risks associated with the radical hormone imbalances induced by these equine hormones. Their… Continue reading Pushing Premarin: Big Pharma, Big Bucks — Part 3

Aprela® — the making of a new pregnant mare’s urine drug

Part 1 of a Special Report by Jane Allin October 3, 2013 looms as the harbinger of foreboding news for PMU mares and their foals. This is the day that the U.S. Food and Drug Administration (FDA) will make a decision whether or not to approve Ligand Pharmaceutical’s dual-acting drug Aprela® for the treatment of… Continue reading Aprela® — the making of a new pregnant mare’s urine drug